Corvus Pharmaceuticals

Corvus Pharmaceuticals

Clinical-stage biopharmaceutical company focused on the development of novel agents that target the immune system to treat patients with cancer.

Launch date
Employees
Market cap
$319m
Enterprise valuation
$272m (Public information from Sep 2024)
Burlingame California (HQ)
Authorizing premium user...